Current Edition

Non-clinical evaluations for anti-cancer
Volume 2 Issue 1

Non-clinical Evaluations for Anti-cancer Drugs with ICH S9 Guideline Q&A – What the Industry Needs to Know

The ICH S9 Guideline Q&A document – published in June 2018 – is designed to clarify some of the most common challenges experienced across the …

Continue Reading →
Raising organisational fluency
Volume 2 Issue 1

Raising Organisational Fluency in Real-world Evidence

The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions, we still lack real-world data …

Continue Reading →
Applying standardised NMR spectroscopy
Volume 2 Issue 1

Applying Standardised NMR Spectroscopy to Research Human Diseases

In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks and how they are continuously …

Continue Reading →
Alzheimer's disease_the way forward
Volume 2 Issue 1

Alzheimer’s Disease: The Way Forward

Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to crack within drug discovery and …

Continue Reading →
Artificial intelligence expands the destiny
Volume 2 Issue 1

Artificial Intelligence Expands the Destiny of DNA Analysis

DNA is the code that has defined humanity for millennia. Until more recently, DNA has determined destiny. There was no escaping its design and code …

Continue Reading →